Ninni Elise Olafsen
Siddhartha Das
Chiara Gorrini
Jason Matthews
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
- 1Department of Nutrition, Institute of Basic Medical Sciences, Faculty of Medicine, University of Oslo, Oslo, Norway
- 2School of Molecular and Cellular Biology, University of Leeds, Leeds, United Kingdom
- 3Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
- 4Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada
By Olafsen NE, Das S, Gorrini C and Matthews J (2024). Front. Oncol. 14:1466658. doi: 10.3389/fonc.2024.1466658
In the published article, there was an error. The the guide oligo sequences describing the gRNA used to target Ahr were incorrect.
A correction has been made to Methods and materials, 2.3 Generation of the PyMT AhrKO cell line. This sentence previously stated:
“Briefly, the guide oligos forward 5´-CCTACGCCAGTCGCAAGCGG-3´ and reverse 5´-CCGCTTGCGACTGGCGTAGG-3´ were annealed and ligated into the pSpCas9(BB)-2A-Puro (PX459) plasmid (Addgene, Watertown, MA, USA; plasmid #62988).”
The corrected sentence appears below:
“Briefly, the guide oligos forward 5´-AAACTCTAAGCGACACAGAGACCGC-3´ and reverse 5´-CACCGCGGTCTCTGTGTCGCTTAGA-3´ were annealed and ligated into the pSpCas9(BB)-2A-Puro (PX459) plasmid (Addgene, Watertown, MA, USA; plasmid #62988).”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: aryl hydrocarbon receptor, BAY2416964, breast cancer, PyMT, GNF351, proliferation, kynurenine
Citation: Olafsen NE, Das S, Gorrini C and Matthews J (2024) Corrigendum: Long-term exposure to BAY2416964 reduces proliferation, migration and recapitulates transcriptional changes induced by AHR loss in PyMT-induced mammary tumor cells. Front. Oncol. 14:1516633. doi: 10.3389/fonc.2024.1516633
Received: 24 October 2024; Accepted: 08 November 2024;
Published: 19 November 2024.
Edited and Reviewed by:
David H. Sherr, Boston University, United StatesCopyright © 2024 Olafsen, Das, Gorrini and Matthews. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Jason Matthews, amFzb24ubWF0dGhld3NAbWVkaXNpbi51aW8ubm8=